Mixed-Use Account Reconciliation

Mixed-Use Account Reconciliation
for 340B Programs

Real-time mixed-use ratio tracking and account reconciliation across inpatient, outpatient, and ambulatory settings. Drug-specific routing logic for accurate 340B vs. non-340B accounting — preventing the documentation drift that triggers most HRSA findings.

<72 HRS

Reconciliation Turnaround

99%+

Drug Routing Accuracy

95%+

Account Reconciliation Accuracy

The Reality

Why Mixed-Use Reconciliation Is the Most Operationally Demanding 340B Discipline?

Continuous Discipline, Not Quarterly Catch-Up

Mixed-use ratios shift daily based on dispensing patterns, patient mix, and encounter eligibility decisions. Quarterly reconciliation lets ratios drift for 90 days before correction — and HRSA reviews look at point-in-time accuracy, not annual averages.

Drug-Level Routing Complexity

The same NDC dispensed to different patients on the same day may require different 340B vs. non-340B routing based on encounter eligibility. Generic mixed-use logic that ignores drug-level decisions produces compliance drift.

Virtual Inventory Coordination

340B virtual inventory operates as a continuous accumulation and replenishment cycle. Mixed-use reconciliation against virtual inventory requires daily transaction-level matching, not month-end summary review.

GPO vs. WAC Pricing Routing

Non-340B portion of mixed-use accounts must be billed against GPO or WAC pricing, not 340B pricing. Routing errors produce duplicate discount exposure and HRSA findings during audit.

Multi-Facility Standardization

Hospital systems with multiple 340B-eligible sites must reconcile mixed-use ratios consistently across facilities — each with its own dispensing patterns, encounter mix, and 340B configuration.

Audit-Ready Documentation Burden

Per-drug, per-encounter mixed-use documentation must be capturable and exportable for HRSA review. Spreadsheet-based reconciliation models cannot produce the documentation HRSA reviews require.

Recent Client Results

Proof From The Field

A 340-bed regional health system reduced mixed-use reconciliation lag from 67 days to 48 hours and identified $940,000 in previously misrouted 340B savings within six months. A 220-bed community hospital corrected drug-level mixed-use routing across all infusion claims and recovered $620,000 in chargeback exposure that had not been caught by their prior 340B vendor. A 4-facility hospital system standardized mixed-use methodology across all sites, eliminating $1.4M in cumulative mixed-use drift identified during retrospective review.

< 72 hrs

Standard Reconciliation Turnaround

Per-claim

Drug-Level Routing
Accuracy

$1M–$3M+

Typical Annual Financial
Impact

How we support you

End-to-End Mixed-Use Reconciliation

AnnexMed delivers 340B mixed-use reconciliation as a three-stage operation — drug-level routing, ratio tracking, and audit-ready documentation — so mixed-use accounts stay reconciled continuously, not quarterly, with per-claim accuracy HRSA reviews require.

Drug-Level Routing

Per-prescription decision logic

Ratio Tracking

Continuous, not quarterly

Audit Documentation

Built for HRSA review

Financial impact

What These Improvements Mean in Dollars?

For a covered entity with $3M–$15M in annual 340B savings and active mixed-use accounts, continuous mixed-use reconciliation drives $1M–$3M+ in recovered savings, prevented errors, and reduced audit exposure. Most covered entities see measurable financial impact within the first 90 days.

Improvement Area

Estimated Annual Impact

Misrouted Savings Recovery (Retrospective)

$500K – $1.4M one-time recovery

Drug-Level Routing Accuracy Recovery

$300K – $940K annually

Chargeback Recovery on Mixed-Use Drift

$200K – $620K annually

Duplicate Discount Prevention

$200K – $700K in prevented recoupment

Virtual Inventory Optimization

$150K – $500K annually

Audit Defense Cost Avoidance

$80K – $250K per audit cycle

Performance Targets vs. Industry Benchmark

KPIs we hold ourselves accountable to — tracked in real time through your operational dashboards

Performance Metric

Industry Benchmark

AnnexMed Target

Reconciliation Turnaround

Industry avg: 30–90 days

< 72 hours

Drug-Level Routing Accuracy

Industry avg: 92–96%

99%+

Mixed-Use Ratio Tracking Cadence

Industry: month-end summary

Real-time

Multi-Facility Standardization

Industry: facility-by-facility variance typical

Continuous

Documentation Completeness

Industry: sampled or post-hoc

100% per claim

Discrepancy Resolution Time

Industry: 30+ days

< 7 days

HRSA Audit Findings on Mixed-Use

Common HRSA finding area

Zero

Virtual Inventory Match Rate

Industry avg: 90–95%

99%+

Why Annexmed?

In-House vs. AnnexMed Partnership

Mixed-use reconciliation is where 340B savings most commonly drift away. Here’s how AnnexMed compares to typical in-house or generalist 340B operations

In-House / Traditional

AnnexMed Partnership

Reconciliation Cadence

Quarterly catch-up; 90 days of drift typical

Continuous reconciliation with 72-hour turnaround

Routing Logic

Patient-level or encounter-level only

Drug-level routing per prescription with encounter integration

Ratio Tracking

Spreadsheet-based, month-end summary

Real-time dashboards by facility, service line, and drug class

Multi-Facility Standardization

Each facility runs its own methodology

Standardized methodology with multi-facility consolidated reporting

Documentation Standard

Sampled or post-hoc reconstructed

Per-claim documentation with full audit trail

Discrepancy Resolution

Surfaces during quarterly review

Real-time alerts with 7-day resolution SLA

Virtual Inventory Coordination

Manual matching, lag and errors common

Automated daily matching with replenishment integration

HRSA Audit Outcome

Mixed-use findings common

Zero findings on mixed-use across client base

Real cost example: 250-bed community hospital with $6M annual 340B savings and active mixed-use

In-House: $240,000 annual cost (1 FTE 340B mixed-use analyst + reconciliation software) + estimated $1.6M annual exposure (90-day drift, drug-level routing errors, audit recoupment risk). AnnexMed: $165,000 annual partnership fee + projected $2.1M annual financial benefit (recovered savings, routing accuracy, audit prevention) = net annual financial benefit of approximately +$1.9M per year.

Technology

Powered by proprietary AI & analytics

AnnexMed’s technology stack was built for payer-specific operational demands, not adapted from provider-side billing tools. Risk adjustment accuracy, payment integrity, and credentialing compliance each require different data models, workflow logic, and reporting architectures than provider RCM. Our platform reflects that.

AI Agents & Automation

AI Agents & Intelligent Automation deploys autonomous AI agents across the full revenue cycle, automating eligibility verification, prior authorization, claims processing, payment posting, and denial management at hospital scale and speed.

Data & Analytics Platform

Data & Analytics Platform delivers real-time Power BI dashboards built for hospital executive visibility, including system-wide KPIs, service line performance, payer analysis, productivity, financial forecasting, and national benchmarking insights.

Intelligent AR Management

Intelligent AR Management handles A/R follow-up at hospital scale with intelligent worklists prioritized by dollar value and aging, payer-specific follow-up rules, automated escalation for high-value accounts, and full accountability for every claim.

Computer Assisted Coding

Computer Assisted Coding orchestrates hospital coding operation, intelligent chart assignment by service line, TAT tracking with SLA monitoring, quality audits with accuracy scoring, and coder performance management at enterprise scale.

Together, these platforms create a fully instrumented RCM operation where nothing falls through the cracks. You don’t interact with these systems directly, but the results they enable show up directly in your financial performance.

Ready to Stop Mixed-Use Drift Eroding Your 340B Savings?

Most covered entities identify $700K–$2M in mixed-use reconciliation gaps and recovery in their first assessment. Schedule a no-obligation Mixed-Use Reconciliation Audit and see what’s been drifting away.

Trusted by 100+ Healthcare Providers | AAPC, AHIMA & AAHAM Certified | SOC 2 Type II | HIPAA Compliant

Payer client outcomes

AnnexMed delivers measurable financial impact within the first 60 to 90 days of engagement. The following represent outcomes from active payer partnerships:

$15M–$40M

Risk
Adjustment

$18M–$50M

Payment
Integrity

6 Weeks

Credentialing Clearance

$15M–$50M+

Revenue
Impact

Case Studies

See the impact we deliver

Discover how AnnexMed reduces denials, accelerates reimbursements, and strengthens financial performance. Backed by measurable outcomes and proven RCM expertise, we deliver operational excellence, revenue stability, and sustainable growth you can trust.

Client Voices

See how our clients succeed

Hear from organizations that trust AnnexMed to reduce denials, accelerate reimbursements, and strengthen cash flow. Our expert support delivers measurable performance gains, operational efficiency, financial stability, and scalable growth.

Claims adjudication backlogs were delaying provider payments and increasing complaint volumes. AnnexMed took over processing, cleared the backlog in 30 days, and improved turnaround by 45%. Provider satisfaction scores climbed significantly, dispute volumes dropped, and our network relationships strengthened significantly.

Dr. Richard Calloway

Horizon Health Plan

Our payer operations team was overwhelmed with member inquiries, provider disputes, and claims rework. AnnexMed brought dedicated support that handled every function with accuracy and speed. Processing errors dropped by 60%, provider abrasion decreased, and our operational costs came down by nearly a third.

Dr. Priya Menon

Crestview Insurance Partners

Managing claims accuracy, provider data, and member support internally was draining our resources. AnnexMed streamlined our payer operations end to end. Claims processing improved, provider onboarding accelerated, and our administrative burden reduced dramatically. They understand payer complexity like no other partner.

Laura Simmons

Meridian Managed Care

Proven RCM expertise. Delivered at scale.

For over 20 years, AnnexMed has delivered RCM solutions nationwide, combining expert billing, coding, and AR support to drive measurable results and growth.

Hospital Solutions

RCM Partners Solutions

Practice Solutions

Payer Solutions

Pharmacy Solutions

Payer Services

Patient Access Services

Medical Coding Services

Revenue Cycle Operations

Revenue Recovery Solutions

Payer Services

Dental Services

Business Intelligence

Mixed-Use Account Reconciliation